1. Home
  2. NVAX vs LEG Comparison

NVAX vs LEG Comparison

Compare NVAX & LEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • LEG
  • Stock Information
  • Founded
  • NVAX 1987
  • LEG 1883
  • Country
  • NVAX United States
  • LEG United States
  • Employees
  • NVAX N/A
  • LEG N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • LEG Home Furnishings
  • Sector
  • NVAX Health Care
  • LEG Consumer Discretionary
  • Exchange
  • NVAX Nasdaq
  • LEG Nasdaq
  • Market Cap
  • NVAX 1.3B
  • LEG 1.3B
  • IPO Year
  • NVAX 1995
  • LEG N/A
  • Fundamental
  • Price
  • NVAX $7.84
  • LEG $9.66
  • Analyst Decision
  • NVAX Hold
  • LEG Hold
  • Analyst Count
  • NVAX 6
  • LEG 4
  • Target Price
  • NVAX $15.00
  • LEG $10.50
  • AVG Volume (30 Days)
  • NVAX 8.6M
  • LEG 1.8M
  • Earning Date
  • NVAX 08-06-2025
  • LEG 07-31-2025
  • Dividend Yield
  • NVAX N/A
  • LEG 2.07%
  • EPS Growth
  • NVAX N/A
  • LEG N/A
  • EPS
  • NVAX 2.54
  • LEG 1.02
  • Revenue
  • NVAX $1,078,718,000.00
  • LEG $4,238,200,000.00
  • Revenue This Year
  • NVAX $52.02
  • LEG N/A
  • Revenue Next Year
  • NVAX N/A
  • LEG $2.12
  • P/E Ratio
  • NVAX $3.08
  • LEG $9.46
  • Revenue Growth
  • NVAX 9.22
  • LEG N/A
  • 52 Week Low
  • NVAX $5.01
  • LEG $6.48
  • 52 Week High
  • NVAX $15.22
  • LEG $14.24
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 48.26
  • LEG 55.35
  • Support Level
  • NVAX $7.57
  • LEG $9.08
  • Resistance Level
  • NVAX $10.64
  • LEG $9.63
  • Average True Range (ATR)
  • NVAX 0.72
  • LEG 0.33
  • MACD
  • NVAX -0.07
  • LEG 0.07
  • Stochastic Oscillator
  • NVAX 29.47
  • LEG 97.09

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About LEG Leggett & Platt Incorporated

Leggett & Platt Inc designs and produces engineered components and products found in homes and automobiles. It operates its business through three segments namely Bedding Products, Specialized Products, and Furniture, Flooring, and Textile Products. It generates the majority of its revenue from Bedding Products. Serving a broad suite of customers around the world, Leggett & Platt's products include bedding components, automotive seat support, and lumbar systems, specialty bedding foam and private label finished mattresses, components for home furniture, and work furniture, flooring underlayment, adjustable beds, and various other products.

Share on Social Networks: